Fake & Overpriced Medicines: What’s Happening in India’s Healthcare System? | Ashwini Upadhyay
Senior Supreme Court Advocate Ashwini Upadhyay has raised serious concerns regarding the Indian healthcare sector during a recent media interaction. He highlighted critical issues involving the circulation of alleged fake medicines and soaring healthcare costs that burden ordinary citizens. The discussion also touched upon alarming claims concerning compromised medical supplies and their severe consequences for public safety. Upadhyay emphasized the urgent need for stringent legal reforms and stricter regulatory enforcement to tackle medical corruption. Authorities face mounting pressure to protect vulnerable patients from exploitation by unscrupulous elements within the pharmaceutical industry. Comprehensive policy changes and transparent monitoring systems are deemed essential to restore public trust in the country's medical infrastructure.
In an exclusive Capital TV podcast, Senior Supreme Court Advocate Ashwini Upadhyay discusses concerns over alleged fake medicines, claims involving animal blood in the human body, and excessive medicine prices in India. What are the legal and public health implications, and what action is needed to protect patients?
Share this story